Gene therapy for RPE65-mediated retinal dystrophies

被引：1
|
作者：
Nagiel, Aaron
机构：
来源：
SURVEY OF OPHTHALMOLOGY | 2018年 / 63卷 / 03期
关键词：
TRIAL;
D O I：
10.1016/j.survophthal.2017.12.006
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：445 / 446
页数：2
相关论文
共 50 条
  • [1] AAV gene replacement therapy for RPE65-mediated inherited retinal dystrophies
    Wu, W.
    He, S.
    Yang, Q.
    Yang, C.
    Zhang, J.
    Song, J.
    Zhu, M.
    Ma, N.
    Zhang, S.
    Jiang, Y.
    Wang, S.
    Shi, L.
    Yao, X.
    Yang, H.
    Luk, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A197 - A198
  • [2] Preclinical Safety Assessment of an Investigational Gene Replacement Therapy for the Treatment of RPE65-Mediated Inherited Retinal Dystrophies
    Wu, Weiwei
    He, Sheng
    Yang, Qi
    Yang, Chenhua
    Zhang, Jingyu
    Song, Jipeng
    Zhu, Mengke
    Shi, Linyu
    Yao, Xuan
    Yang, Hui
    MOLECULAR THERAPY, 2023, 31 (04) : 171 - 171
  • [3] COSTS AND QUALITY OF LIFE OF RPE65-MEDIATED INHERITED RETINAL DYSTROPHIES IN PORTUGAL
    Ascencao, R.
    Paquete, A. T.
    Santos, L. C.
    Silva, E.
    Cunha, J. P.
    Lume, M.
    Silva, R. S.
    Borges, M.
    Silva Miguel, L.
    VALUE IN HEALTH, 2020, 23 : S735 - S735
  • [4] The Natural History of Disease Progression in Patients With RPE65-Mediated Inherited Retinal Dystrophies
    Chung, Daniel C.
    Wellman, Jennifer
    Liu, Emily
    Reape, Kathy
    Pappas, Julie
    Elci, Okan
    McCague, Sarah
    High, Katherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] Gene therapy for RPE65-mediated inherited retinal dystrophy completes phase 3
    Lee, Helena
    Lotery, Andrew
    LANCET, 2017, 390 (10097): : 823 - 824
  • [6] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Daniel Viriato
    Natalie Bennett
    Raisa Sidhu
    Elizabeth Hancock
    Hannah Lomax
    David Trueman
    Robert E. MacLaren
    Advances in Therapy, 2020, 37 : 1233 - 1247
  • [7] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Viriato, Daniel
    Bennett, Natalie
    Sidhu, Raisa
    Hancock, Elizabeth
    Lomax, Hannah
    Trueman, David
    MacLaren, Robert E.
    ADVANCES IN THERAPY, 2020, 37 (03) : 1233 - 1247
  • [8] Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
    Simone A. Huygens
    Matthijs M. Versteegh
    Stefan Vegter
    L. Jan Schouten
    Tim A. Kanters
    PharmacoEconomics, 2021, 39 : 383 - 397
  • [9] Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy
    Lloyd, Andrew
    Piglowska, Natalia
    Ciulla, Thomas
    Pitluck, Sarah
    Johnson, Scott
    Buessing, Marric
    O'Connell, Thomas
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (11) : 1610 - 1614
  • [10] Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
    Huygens, Simone A.
    Versteegh, Matthijs M.
    Vegter, Stefan
    Schouten, L. Jan
    Kanters, Tim A.
    PHARMACOECONOMICS, 2021, 39 (04) : 383 - 397
12345